Previous 10 | Next 10 |
Aspira Women's Health ( NASDAQ: AWH ) priced its stock offering it released late on Monday at $9M, comprising the sale of 12M common shares priced at $0.75 apiece. The provider of diagnostic tests for gynecologic disease told the offering will also include the accompan...
AUSTIN, Texas, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offerin...
Aspira Women’s Health ( NASDAQ: AWH ), a provider of diagnostic tests for gynecologic disease, lost ~23% in the post-market trading Monday after the company announced an underwritten public offering of its common stock and warrants. AWH has selected William Blai...
AUSTIN, Texas, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced it has commenced an underwritten public offering of shares of its c...
AUSTIN, Texas, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced that it will host a key opinion leader (KOL) webinar on women’s health and...
Image source: The Motley Fool. Aspira Women's Health Inc. (NASDAQ: AWH) Q2 2022 Earnings Call Aug 10, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Aspira Women's Health Inc. (AWH) Q2 2022 Earnings Call Transcript...
Aspira Women's Health, Inc. (AWH) Q2 2022 Earnings Conference Call August 10, 2022 08:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Robert Beechey - Chief Financial Officer Ryan Phan - Chief Scientific Officer and Chief Ope...
Aspira Women’s Health press release ( NASDAQ: AWH ): Q2 GAAP EPS of -$0.07 in-line. Revenue of $2.06M (+14.4% Y/Y) misses by $0.34M . For further details see: Aspira Women’s Health GAAP EPS of -$0.07 in-line, revenue of $2.06M misses by $0.34M ...
Increased product revenue by 17% to $2.0 million; Grew OVA1plus volume by 19% to 5,411 units Entered into a research agreement with Harvard’s Dana Farber Cancer Institute, Brigham & Women’s Hospital, and Medical University of Lodz for development of a d...
AUSTIN, Texas, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced that the company will report its financial results for the second quarter ended J...
News, Short Squeeze, Breakout and More Instantly...
Aspira Women's Health Inc. Company Name:
AWH Stock Symbol:
NASDAQ Market:
Aspira Women's Health Inc. Website:
Preliminary OvaWatch ® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuite SM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Heal...
AUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that i...
AUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it has...